Harry Shuman

Harry Shuman

Comptroller/Controller/Auditor bei MERUS N.V.

Vermögen: 372 786 $ am 31.05.2024

Health Technology

Ursprung des Netzwerks ersten Grades von Harry Shuman

EinheitArt der EinheitIndustrie
Public Company Biotechnology 20

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Harry Shuman

UnternehmenSektorVerknüpfte PersonenHauptposition
Pharmaceuticals: Major

Bill Lundberg

Chief Tech/Sci/R&D Officer

Biotechnology

Len Kanavy

Corporate Officer/Principal

INCYTE CORPORATION Pharmaceuticals: Major

Victor Sandor

Chief Tech/Sci/R&D Officer

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Bill Lundberg

Corporate Officer/Principal

Rochester Christian University College/University

Peter Silverman

Undergraduate Degree

ARRAY TECHNOLOGIES, INC. Pharmaceuticals: Major

Victor Sandor

Jason Haddock

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

Medical Specialties

Bill Lundberg

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Antisoma Research Ltd.

Bill Lundberg

Corporate Officer/Principal

KALA BIO, INC. Pharmaceuticals: Major

Gregory Perry

Mark Iwicki

Director/Board Member

Chief Executive Officer

ACLARIS THERAPEUTICS, INC. Pharmaceuticals: Major

Maxine Gowen

Anand Mehra

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Investment Managers

Mark Iwicki

Consultant / Advisor

McGill University College/University

Victor Sandor

Doctorate Degree

Massachusetts Institute of Technology College/University

Bill Lundberg

Andrew Joe

Undergraduate Degree

Undergraduate Degree

College/University

Sherri L. Spear

Undergraduate Degree

Loyola University Maryland, Inc. College/University

Mark Iwicki

Masters Business Admin

University of Massachusetts College/University

Bill Lundberg

Masters Business Admin

University of Scranton College/University

Len Kanavy

Masters Business Admin

Pharmaceuticals: Major

Mark Iwicki

Corporate Officer/Principal

Pharmaceuticals: Major

Alexander Berthold Hendrik Bakker

Corporate Officer/Principal

University of Utrecht College/University

John de Kruif

Cecilia Anna Wilhelmina Geuijen

Doctorate Degree

Doctorate Degree

Radboud University Nijmegen College/University

Alexander Berthold Hendrik Bakker

Doctorate Degree

Icahn School of Medicine at Mount Sinai College/University

Andrew Joe

Graduate Degree

Investment Managers

Sherri L. Spear

Analyst-Equity

Medical/Nursing Services

Bill Lundberg

Director/Board Member

Stanford University School of Medicine College/University

Bill Lundberg

Doctorate Degree

The Isenberg School of Management College/University

Bill Lundberg

Masters Business Admin

CRISPR THERAPEUTICS AG Biotechnology

Bill Lundberg

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

VOR BIOPHARMA INC. Biotechnology

Bill Lundberg

Director/Board Member

Biotechnology

Mark Iwicki

Bill Lundberg

Chairman

Director/Board Member

Movies/Entertainment

Mark Iwicki

Director/Board Member

AKERO THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

AEROVATE THERAPEUTICS, INC. Biotechnology

Mark Iwicki

Director/Board Member

THIRD HARMONIC BIO, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

Genentech Access To Care Foundation

Len Kanavy

Director/Board Member

Statistik

International

Vereinigte Staaten 38
Niederlande 5
Vereinigtes Königreich 4
Kanada 2
Schweiz 2

Sektoral

Health Technology 23
Consumer Services 13
Finance 8
Commercial Services 3
Health Services 2

Operativ

Director/Board Member 73
Corporate Officer/Principal 39
Independent Dir/Board Member 37
Director of Finance/CFO 16
Undergraduate Degree 13
  1. Börse
  2. Insiders
  3. Harry Shuman
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT